Canada Pension Plan Investment Board’s Wave Life Sciences WVE Stock Holding History

Canada Pension Plan Investment Board’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$122K	Buy	+16,800	New	+$219K	﹤0.01%	1634

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Canada Pension Plan Investment Board's WVE Position: Q1 2026 in Review

Canada Pension Plan Investment Board opened a new position in Wave Life Sciences (WVE) in Q1 2026: 16,800 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #1634 among its holdings.

230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Canada Pension Plan Investment Board held 16,800 shares of Wave Life Sciences worth $122K as of Q1 2026.
Wave Life Sciences was a new Canada Pension Plan Investment Board position in Q1 2026.
Wave Life Sciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1634 holding.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.